论文部分内容阅读
在部分含有西布曲明的减肥药下架召回事件中,很多问题值得深思。现在看来,我国的药品召回制度亟待完善。首先,药品召回必须公开透明。《药品召回管理办法》没有对企业及时、全面地公开药品召回信息提出要
Many issues are worth pondering over the recall of some weight-loss drugs that contain sibutramine. It now appears that China’s drug recall system needs improvement. First, drug recalls must be open and transparent. “Drug Recall Management Measures” did not promptly and fully disclose the drug recall information to enterprises